as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD). Nucala stands out as the only approved biologic that has been ...

The conditions of participants ranged from moderate to severe, or stages 2–4 as assessed by the medically recognized scale of the Global Initiative for Chronic Obstructive Lung Disease (GOLD). During ...

In a large US cohort study, pre-pandemic severe obstructive ... with disease, affecting population representativeness. This study was supported by a grant from the National Heart, Lung, and ...

Examining a patient for common or complex pulmonary issues in a primary care setting takes time and expertise — physicians need to ask about symptoms and medical history and determine which ...

chronic lung disease prevents the lungs and respiratory system from working correctly. It manifests in three ways: restrictive lung diseases, obstructive lung diseases and pulmonary vascular diseases.

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of ...

as it is known that diseases accompanied by restrictive patterns are more difficult to diagnose in comparison to healthy subjects and patients with chronic obstructive pulmonary disease (COPD).3 ...

Norwegian Crown Princess Mette-Marit's chronic lung disease has worsened to the point where it’s affecting "her ability to perform her duties," the Royal House of Norway announced. Mette-Marit ...

A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease ... therapy for chronic obstructive pulmonary disease, which completed ...

The study revealed that higher long-term relative humidity (RH) exposure was associated with a lower risk of restrictive lung disease ... elevated RH may exacerbate conditions linked to obstructive ...

Amgen is discontinuing a lung disease program after its investigational small molecule failed to hit any of the primary or secondary endpoints in a midstage study. The asset at play is ...

Objectives Diagnosis and assessment of chronic obstructive ... or restrictive lung diseases, including large pleural effusion, extensive pleural thickening, severe thoracic deformity, severe thoracic ...